A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells-Reference-Cited by-同舟云学术

A bispecific nanobody approach to leverage the potent and widely applicable tumor cytolytic capacity of Vγ9Vδ2-T cells

Published:2017-10-20 Issue:1 Volume:7 Page:e1375641
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

de Bruin Renée C. G.¹,Veluchamy John P.¹,Lougheed Sinéad M.¹,Schneiders Famke L.¹,Lopez-Lastra Silvia²³⁴,Lameris Roeland¹,Stam Anita G.¹,Sebestyen Zsolt⁵,Kuball Jürgen⁵,Molthoff Carla F. M.⁶,Hooijberg Erik⁷,Roovers Rob C.⁸^ORCID,Santo James P. Di²³^ORCID,van Bergen en Henegouwen Paul M. P.⁸^ORCID,Verheul Henk M. W.¹,de Gruijl Tanja D.¹,van der Vliet Hans J.¹

Affiliation:

1. Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands

2. Innate Immunity Unit, Institut Pasteur, Paris, France

3. Institut National de la Santé et de la Recherche Médicale (INSERM) U1223, Paris, France

4. Université Paris-Sud, Université Paris-Saclay, Gif-sur-Yvette, France

5. Department of Hematology and Laboratory of Translational Immunology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands

6. Department of Radiology and Nuclear Medicine, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands

7. Department of Pathology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands

8. Department of Cell Biology, Faculty of Science, Utrecht University, Padualaan 8, 3584 CH, Utrecht, The Netherlands

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1375641

Reference71 articles.

1. γ9 and δ2CDR3 domains regulate functional avidity of T cells harboring γ9δ2TCRs

2. Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas

3. Phosphostim-Activated γδ T Cells Kill Autologous Metastatic Renal Cell Carcinoma

4. Synthetic Phosphoantigens Enhance Human Vγ9Vδ2 T Lymphocytes Killing of Non-Hodgkin’s B Lymphoma

5. Vγ9Vδ2 T Cell Response to Colon Carcinoma Cells

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges;Molecular Biotechnology;2024-09-02

2. A novel bispecific T-cell engager using the ligand-target csGRP78 against acute myeloid leukemia;Cellular and Molecular Life Sciences;2024-08-28

3. Single-domain antibodies as therapeutics for solid tumor treatment;Acta Pharmaceutica Sinica B;2024-07

4. Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions;mAbs;2024-04-26

5. New immune cell engagers for cancer immunotherapy;Nature Reviews Immunology;2024-01-25